The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $34 million in the period, also topping ...
News
- Xencor: Q1 Earnings Snapshot
- Ocular Therapeutix: Q1 Earnings Snapshot
The biotechnology company posted revenue of $7.3 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected ...
- Harvard Bioscience: Q1 Earnings Snapshot
Barbacoa ready to serve Saturday Sept. 19, 2015 at Adelita Tamales & Tortilla Factory · Locals dish on the best barbacoa spots in San Antonio · @ ...
- 22nd Century: Q1 Earnings Snapshot
The plant biotechnology company posted revenue of $6.8 million in the period. The company's shares closed at $4.03. A year ago, they were trading ...
- Moderna: Q1 Earnings Snapshot
The biotechnology company posted revenue of $1.94 billion in the period, which fell short of Street forecasts. Six analysts surveyed by Zacks expected ...